RecruitingNot ApplicableNCT06644222

Effectiveness of Airrosti and TheraBand Exercises on Double-Crossed Syndrome in Smart Phone User's Shoulder

The Effectiveness of Airrosti and TheraBand Exercises on Pain and Disability on Double-Crossed Syndrome in Smart Phone User's Shoulder


Sponsor

Majmaah University

Enrollment

60 participants

Start Date

Dec 10, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Double-crossed syndrome" refers to a specific alignment of overactive and underactive muscles in the neck, chest, and shoulders. AIRROSTI stands for Applied Integration for the Rapid Recovery of Soft Tissue Injuries. This study aims to evaluate the effectiveness of Airrosti exercises combined with TheraBand exercises in reducing pain and disability in the neck and shoulders. TheraBand exercise programs are commonly used to improve muscle activation. However, research on the effectiveness of AIRROSTI combined with TheraBand exercises for treating Double-Crossed Syndrome among smartphone users is limited, and more evidence is needed to support their effectiveness.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 25 Years

Inclusion Criteria1

  • young female participants with rounded shoulder postures. Participants aged between 18 and 25 years. No history of shoulder trauma, current shoulder pathology, thoracic scoliosis, and kyphosis deformity.

Exclusion Criteria1

  • Participants excluded if they received any other form of medical treatment or have thoracic scoliosis or kyphosis deformity.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALAIRROSTI exercises

Group A will receive AIRROSTI exercises for 45 minutes / one session daily for five days per week

BEHAVIORALThera band exercises

Group B will receive Thera band exercises for 45 minutes/one session per day for five days per week.


Locations(1)

Majmaah University

Al Majma'ah, Alriyadh, Saudi Arabia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06644222


Related Trials